Equities analysts expect that LHC Group (NASDAQ:LHCG) will post $252.84 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for LHC Group’s earnings. The lowest sales estimate is $251.10 million and the highest is $254.23 million. LHC Group posted sales of $226.03 million during the same quarter last year, which suggests a positive year-over-year growth rate of 11.9%. The business is expected to report its next earnings results after the market closes on Wednesday, August 2nd.

On average, analysts expect that LHC Group will report full-year sales of $252.84 million for the current year, with estimates ranging from $1.02 billion to $1.03 billion. For the next financial year, analysts forecast that the business will report sales of $1.10 billion per share, with estimates ranging from $1.08 billion to $1.12 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that follow LHC Group.

LHCG has been the topic of a number of research reports. Royal Bank Of Canada restated a “buy” rating and issued a $69.00 price objective on shares of LHC Group in a report on Monday, May 15th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $68.00 price objective (up previously from $55.00) on shares of LHC Group in a report on Monday, May 8th. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a report on Thursday, July 6th. Jefferies Group LLC raised their price objective on LHC Group from $56.00 to $65.00 and gave the company a “buy” rating in a report on Monday, May 15th. Finally, Benchmark Co. raised their price objective on LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, June 8th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $64.38.

Shares of LHC Group (NASDAQ:LHCG) opened at 63.43 on Friday. The company has a market cap of $1.16 billion, a PE ratio of 29.37 and a beta of 0.80. LHC Group has a 12 month low of $32.04 and a 12 month high of $69.35. The company has a 50-day moving average of $65.38 and a 200 day moving average of $55.22.

In other news, Director Coliseum Capital Management, L sold 14,450 shares of LHC Group stock in a transaction on Friday, June 16th. The stock was sold at an average price of $65.69, for a total transaction of $949,220.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of LHC Group stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the transaction, the chief operating officer now owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last quarter, insiders have sold 682,839 shares of company stock worth $42,140,531. Insiders own 14.80% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of LHCG. Russell Investments Group Ltd. bought a new position in LHC Group during the fourth quarter valued at approximately $1,535,000. Comerica Bank raised its position in LHC Group by 5.8% in the fourth quarter. Comerica Bank now owns 15,836 shares of the health services provider’s stock valued at $732,000 after buying an additional 863 shares in the last quarter. State Street Corp raised its position in LHC Group by 7.8% in the fourth quarter. State Street Corp now owns 373,936 shares of the health services provider’s stock valued at $17,094,000 after buying an additional 26,915 shares in the last quarter. Thrivent Financial for Lutherans raised its position in LHC Group by 5.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 8,050 shares of the health services provider’s stock valued at $368,000 after buying an additional 450 shares in the last quarter. Finally, Norges Bank bought a new position in LHC Group during the fourth quarter valued at approximately $7,913,000. Institutional investors and hedge funds own 84.56% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/07/23/brokerages-expect-lhc-group-nasdaqlhcg-will-post-quarterly-sales-of-252-84-million.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.